10th Annual Pittsburgh International Lung Conference

Personalized medicine holds great potential for improving patient care and health care efficiency. Thanks to ever emerging advances in parsing the molecular basis of disease, physicians and scientists are developing approaches for detecting a person’s genetic risk for medical conditions and for providing targeted care that could help prevent, treat, or cure disease. Personalized medicine has already begun changing the face of healthcare and the expectations of patients. In lung disease, it may be used to optimize both preventative and therapeutic patient care. Personalized medicine is a nascent field, yet it is expected to revolutionize medical care as it shifts medicine’s emphasis from reacting to disease to preventing it.

This conference will be an intensive, two-day meeting featuring presentations from over 50 experts in the field. On Friday evening, there will be a banquet dinner featuring a featured presentation by William A. Gahl, MD, PhD, Clinical Director of the National Human Genome Research Institute. The conference will focus on personalized approaches that address pulmonary conditions such as asthma, chronic obstructive pulmonary disease, acute lung injury, idiopathic pulmonary fibrosis, sarcoidosis, cystic fibrosis, alpha-1 antitrypsin deficiency and pulmonary vascular disease, among others. Each session will describe the state of knowledge and current and potential applications of personalized medicine to lung disease.

Visit http://www.strategicresults.com/upitt/ for more information.

Pittsburgh International Lung Conference
Personalized Medicine of Lung Disease
October 28-29, 2011 in Pittsburgh, Pennsylvania.